Corporate ActionMay 5, 2026, 04:57 PM
Sonoma Pharmaceuticals Proposes Reincorporation to Nevada
AI Summary
Sonoma Pharmaceuticals, Inc. is holding a Special Stockholders' Meeting on June 24, 2026, to vote on reincorporating the company from Delaware to Nevada. The Board of Directors recommends approval, citing expected annual savings of approximately $200,000 in Delaware franchise taxes and enhanced protection for directors and officers under Nevada law. The reincorporation is also intended to provide greater corporate flexibility.
Key Highlights
- Special Stockholders' Meeting scheduled for June 24, 2026, at 2:00 p.m. MDT.
- Proposal 1: Authorize reincorporation from Delaware to Nevada.
- Proposal 2: Authorize adjournment to solicit additional proxies if needed.
- Record date for voting is April 28, 2026.
- Expected annual savings of approximately $200,000 in Delaware franchise taxes.
- Nevada annual fees will be $500 for business license and $150 for officer list.
- Reincorporation aims to reduce litigation risk and provide greater protection for directors and officers.
- Requires affirmative vote of a majority of outstanding common stock for reincorporation.
Price Impact
More from SNOA
Business Update3h ago
Sonoma Pharmaceuticals Expands Product Reach with Multiple Launches
Corporate ActionApr 30, 5:02 PM
SNOA Prices $4.0M Public Offering; Expects $3.5M Net Proceeds
Contract WinApr 9, 8:32 AM
Sonoma Pharmaceuticals Enters Manufacturing and Supply Agreement with Kenvue Brands for Microcyn® Products in US